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ABSTRACT
RAT BLOOD PROFILE EVALUATION AFTER Fe3O4/CHITOSAN COLLOID INJECTION.
The application of iron oxide (Fe3O4) magnetic nanoparticles in the biomedical field is still being explored,
mainly related to its toxicity and side effects. This article reported results of the study aimed at analyzing the
effect of chitosan-coated magnetic nanoparticles (NPM-C) on rat blood profiles. Magnetic colloid as much as
1 mL (concentration of 5 mg NPM-C/mL aquabidest) for 1 kG rat body weight was injected through intra-
venous to the treated rat group (4 Wistar rats aged 6 months; weight ± 275 grams; male sex) while another four
rats injected with sterile aquabidest used as a control group. The blood taking from each group of rats was
carried out on 1 day before injection and several days after injection (days 1, 7, 14, 21, 28) through veins in the
tail. To these blood samples, a series of blood profile analyzes is carried out including basic hematology, blood
chemistry, and fragility of the erythrocyte membrane. The results of the analysis showed no significant
differences between blood profiles after treatment and control, which indicated that chitosan-coated magnetic
nanoparticles did not trigger cellular stress responses in the blood. The stability of blood magnetism analyzed
by VSM (Vibrating Sample Magnetometer) also shows that magnetic nanoparticles are detected in the blood
and tend to decrease in number with increasing time, so it is thought that these nanoparticles can be degraded
or have been distributed into organs. These stable properties are analyzed due to an existence of chitosan
coating around magnetic nanoparticles. Based on this study it can be concluded that up to the given concentration
limit, iron oxide nanoparticles coated by chitosan are not toxic and have the potential to be used as drug carriers,
MRI contrast agents, and other biomedical applications.
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ABSTRAK
EVALUASI PROFIL DARAH TIKUS SETELAH INJEKSI KOLOID Fe3O4/CHITOSAN. Penerapan
nanopartikel magnetik oksida besi (Fe3O4) di bidang biomedis masih dieksplorasi, terutama terkait dengan
toksisitas dan efek sampingnya. Artikel ini melaporkan hasil penelitian yang bertujuan menganalisis efek
nanopartikel magnetik berlapis kitosan (NPM-C) pada profil darah tikus. Koloid magnetik sebanyak 1 mL
(konsentrasi 5 mg NPM-C/mL aquabidest) untuk 1 kG berat badan tikus disuntikkan melalui vena ke kelompok
tikus yang dirawat (4 tikus Wistar berusia 6 bulan; berat ± 275 gram; jantan jenis kelamin) sementara empat
tikus lainnya disuntik dengan aquabidest steril yang digunakan sebagai kelompok kontrol. Pengambilan darah
dari masing-masing kelompok tikus dilakukan pada 1 hari sebelum injeksi dan beberapa hari setelah injeksi (hari
1, 7, 14, 21, 28) melalui vena di ekor. Untuk sampel darah ini, serangkaian analisis profil darah dilakukan
termasuk hematologi dasar, kimia darah, dan kerapuhan membran eritrosit. Hasil analisis menunjukkan tidak
ada perbedaan yang signifikan antara profil darah setelah perawatan dan kontrol, yang menunjukkan bahwa
nanopartikel magnetik berlapis kitosan tidak memicu respons stres seluler dalam darah. Stabilitas magnet darah
yang dianalisis oleh VSM (Vibrating Sample Magnetometer) juga menunjukkan bahwa nanopartikel magnetik
terdeteksi dalam darah dan cenderung berkurang jumlahnya seiring bertambahnya waktu, sehingga diduga
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INTRODUCTION
Nanomaterial applications in the field of
biomedical have been researched and developed in this
last decade. Nano-sized particles were being developed
to be used as drug delivery systems [1]. Iron oxide
magnetic nanoparticles (Fe3O4) are one of the
nanomaterials that are approved in clinical use. These
particles have also been used for protein immobilization
and the separation of proteins or enzymes [2]. In addition,
this nanomaterial was also developed as a contrast
material in the diagnostic process by magnetic resonance
imaging (MRI) [3].
The use of magnetic nanoparticles in the
biomedical field still raises concerns about its toxicity
and other side effects on health. Various studies have
been carried out to determine the level of safety and
possible biological impacts [4]. Various ways have been
done to make magnetic nanoparticles that are safe to
use for the body. One way is to coating nanoparticles
with organic polymers or biodegradable polymers.
Coating with biodegradable polymers is expected to
produce a magnetic nanoparticle system that is not toxic
and does not cause blood clots, or blockage of blood
vessels.
Biodegradable polymers are chemical compounds
that can be accepted by the body and do not cause
negative effects. Some commonly known biodegradable
polymers are poly lactic-co-glycolic acid (PLGA),
Polylactid acid (PLA) and Poly(N-isopropylacrylamide)
[5]. Another biodegradable polymer that has the potential
to be used as a nanoparticle coating is chitosan. Chitosan
is a natural biopolymer with reactive amino groups and
functional hydroxyl groups. Chitosan can be
synthesized from chitin, have biocompatibility
properties, good adhesion properties, non-toxic, stable,
mechanically strong and has high hydrophilicity [6].
Previous research has shown that insulin loaded
chitosan nanoparticles system can be a promising
alternative dosage form for oral protein delivery [7].
However, chitosan-coated magnetic nanoparticles have
not been widely studied in vivo to determine their effect
on blood profiles.
Blood is a body fluid consisting of the liquid
component in the form of plasma and blood cells in
the form of white blood cells (leukocytes), red blood
cells (erythrocytes), and blood platelets (platelets),
each of which has a specific function [8]. Blood plays
a role in the regulation of body physiology,
transportation, and the body’s defense against
foreign objects. Changes in blood profile can be used
as an indicator of the body’s response to foreign
objects that enter the body. Therefore, a study on
blood profile before and after nanoparticle injection
could be used to determine toxicity of nanoparticle to
the body.
In this study, magnetic nanoparticles of iron
oxide (Fe3O4) dispersed in a water medium and formed
stable colloids were injected intra-vein in test animal
(Wistar rat) and their effects on several blood profile
parameters were analyzed from rat blood samples
taken as a function of time. Magnetic analysis of blood
samples was also carried out to obtain profile changes
of magnetic nanoparticles in the blood. The analysis
was carried out using Vibrating Sample Magnetometer
(VSM).
ANIMAL ETHIC STATEMENT
This study has followed a code of ethics approved
by the Ethics Committee of the Faculty of Veterinary
Medicine, Bogor Agricultural University (FKH-IPB)
related to the use of animals as research subjects.
EXPERIMENTAL METHOD
Materials and Equipment
The magnetic colloid used was provided from
the Advanced Materials and Technology Center
Laboratory (PSTBM)-BATAN with 5 mg/mL magnetic
nanoparticle concentration with water as a medium and
chitosan as a coating [9]. The 8 rats (Wistar rats age 6
months; ± 275 grams weight; male sex) used were sterile
mice from PT. IndoAnilab PSSP which has been given
standard feed (Indonesia Formula Feed). Another reagent
is ketamine, xylazine, hayem solution, turkish solution,
methanol, giemsa dye, Buffer Neutral Formaline (BNF),
saline and NaCl solution.
The tools used were rat cages (temperature 22-25
°C; humidity 55-63%; light control 12 hours bright and
12 hours dark), syringes, perfusion equipment, camera
light microscopes and other equipment commonly used
for profile analysis blood. Vibrating Sample
Magnetometer (VSM) Oxford 1.2H was used for
characterizing blood magnetic properties.
bahwa nanopartikel ini dapat terdegradasi atau telah didistribusikan ke dalam organ. Sifat-sifat stabil ini dianalisis
karena adanya lapisan kitosan di sekitar partikel nano magnetik. Berdasarkan penelitian ini dapat disimpulkan
bahwa hingga batas konsentrasi yang diberikan, nanopartikel besi oksida yang dilapisi oleh kitosan tidak
beracun dan berpotensi untuk digunakan sebagai pembawa obat, agen kontras MRI, dan aplikasi biomedis
lainnya.
Kata kunci: Iron oxide, Nanopartikel magnetik, Profil darah, Tikus Wistar, VSM
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Animal Preparation and Treatment
This study used 8 male rats with 2 different
treatments. Before being treated, rats were acclimatized
for one week. After acclimatization, rats were divided
into two groups randomly. One group becomes a control
while the other group is treated. The control group
consisted of four rats given sterile aqua-bidest injection,
while the treatment group was given injection of
magnetic nanoparticles with normal doses consisting of
four rats following the method of Kim et al. [10] with time
modification.
Magnetic colloids of 1 ml / Kg of body weight
were intra-venously injected in rats of the treatment
group while rats injected with sterile aqua-bidest were
used as controls. The blood taking from each group of
rats was carried out on 1 day before injection and several
days after injection (day(s) 1, 7, 14, 21, 28) through veins
in the tail.
Basic Hematology Observation
Blood-based hematology analysis was carried
out by a standard method [11] which aims to determine
blood conditions in general. Blood profiles observed
were erythrocyte count, leukocyte count, hemoglobin
value and hematocrit value. Basic hematological data
were analyzed by Anova technique [12].
Fragility of Erythrocyte Membrane
Fragility of erythrocyte membranes was analyzed
through the Osmotic Fragility Test (OFT) [13] by
modifying the concentration of NaCl solution. The level
of erythrocyte membrane strength can be known through
the OFT by inserting erythrocytes into hypertonic,
isotonic and hypotonic solutions in various
concentrations. The solution used is NaCl with levels of
0.3% - 0.9%. Various concentrations of NaCl solution
were added as much as 5 ml in a test tube serially. Each
tube is added with 5 drops of rat blood. The solution is
homogenized and allowed to stand for three hours.
Erythrocyte damage was observed by looking at the
formation of separate layers.
Blood Chemistry Analysis
Blood chemistry analysis is done by using blood
analysis services from PSSP. The parameters observed
were Blood Ureum Nitrogen (BUN), creatinine, total
protein, albumin, globulin, total bilirubin, Alanine
Aminotransferase (ALT), and Alkaline Phosphatase
(ALP).
Blood Magnetism Analysis
The magnetic properties of the blood were
analyzed using the Vibrating Sample Magnetometer
(VSM), in the PSTBM-BATAN laboratory [14]. A total of
10 µL of blood is inserted into the microcapillary tubes.
The test is carried out at room temperature with an
external magnet of 1 T and the speed of data acquisition
is 0.25 T / minute.
RESULT AND DISCUSSION
This study used two groups of rats namely
control and treatment. Each group consisted of four
acclimatized rats. But on the 6th day after injection, one
of the control rats was dead. Death is not caused by
injection, but it is influenced by rat behavior. One rat
from the control group showed aggressive symptoms
from the first day of acclimatization. Aggressive behavior
continues to increase during acclimatization and
continues with activities of self-mutilation. Henceforth,
this study still uses two test groups with a comparison
of three control rats and four treatment rats to observe
their blood profile.
Basic hematology
Figure 1 to Figure 4 show the data of erythrocytes
count, leucocytes count, hematocrit value and
hemoglobin level for each time of blood sample
withdrawn respectively. All the graphical picture present
of almost no significance difference between control and
treated samples for each time point. The stable value of
erythrocytes counts indicates that magnetic
nanoparticles may not interfere with the number of red
blood cells, so they do not interfere with the function of
erythrocytes in the body. Previous studies have reported
that the use of Fe2O3 nanoparticles (25 mg/L) does not
have a significant effect on the number of red blood
cells  [15]. Medina-Ramirez et al. [16] also reported the
use of TiO2-Fe3+ nano-powder are not toxic to red blood
cells.
The absence of differences in the number of
leukocytes indicates that the use of nanoparticles may
Figure 1. Changes in the number of rat erythrocytes
before treatment and 4 weeks after injection of magnetic
nanoparticles. The number of erythrocytes was not
significantly different between treatment and control
(Anova; P> 0.01).
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not interfere with the body’s immune system. The main
function of leukocytes is to recognize, digest cells or
foreign proteins, kill pathogens and specific immune
systems [17]. The absence of changes in leukocyte
counts proves that there is no stimulation of specific
immune responses due to injection of nanoparticles [18].
This result is also in line with the research of Javanovic
et al. [19] who reported that the use of TiO2 nanoparticles
did not cause any changes in the number of neutrophils
as one type of leucocytes.
The effect of the use of magnetic nanoparticles
was also analyzed for hematocrit values which is define
as the percentage of erythrocytes per 100 ml of blood.
Besides being associated with the number of
erythrocytes, hematocrit values   are also closely related
to the value of hemoglobin in the blood. Hematocrit value
analysis was performed to confirm the effect of magnetic
nanoparticles on the number of erythrocytes. The test
results also showed that there were no significant
differences between the treatment and control groups
for each time point (Figure 3). The hematocrit value still
shows that magnetic nanoparticles may not have a
negative effect on the health of the body. Other studies
have shown that changes in hematocrit values   can
occur due to dehydration, body activity and temperature,
environmental conditions, and erythrocyte swelling [20].
Based on these results, the hematocrit levels obtained
are in the ranged of 40%, which level is normal in men
[21] and support the data that the injected nanoparticles
does not have a negative impact on the number of
erythrocytes in the body and no effect on physiological
processes.
Hemoglobin is a red pigment that carries oxygen
in erythrocytes, which amount is closely related to the
number of erythrocytes and blood hematocrit values
(Swenson 1993). Hemoglobin levels in the body can be
influenced by microminerals, vitamins, oxygen levels,
gender and age (Patria et al. 2013). Hemoglobin levels in
both treatment and control were relatively stable at
around 15 g / dl (Figure 4), so the possibility of treatment
did not affect hemoglobin levels. Normal hemoglobin in
men ranges from 13-18 g/dl [21].
All this absence of significance difference in
baseline hematology (erythrocyte count, leukocyte
count, hematocrit value, and hemoglobin level) indicated
that injection of chitosan-coated magnetic nanoparticles
did not cause cellular stress. While the use of other
nanoparticles such as Fe2O3 through veins in mice for
28 days gives rise to an inflammatory response that
induces oxidative stress adversely affects cellular
function [22]. Chen et al. [23] have also examined that
administration of Fe3O4 magnetic nanoparticles without
coating material via intravenously for 72 hours causes
differences in immune responses (CD4 + and CD8 + T
lymphocytes) which depend on the dose-dependent
response. It is proved then, that the existence of chitosan
coating around Fe3O4 nanoparticle will give more
biocompatible surface, causing good recognition and
interaction of the particles to the blood cells and
environment.
Fragility of Erythrocyte Membrane
Erythrocyte membrane fragility describes the
limits of the strength of erythrocyte membranes to resist
pressure until hemolysis occurs. Fragility testing using
Figure 2. Changes in the number of rat leukocytes before
treatment and 4 weeks after injection of magnetic
nanoparticles. The number of erythrocytes was not
significantly different between treatment and control
(Anova; P> 0.01).
Figure 3. Changes in the hematocrit value of rats before
treatment and 4 weeks after injection of magnetic
nanoparticles. Hematocrit values were not significantly
different between treatment and control (Anova; P> 0.01).
Figure 4. Changes in hemoglobin levels of rats before
treatment and 4 weeks after injection of magnetic
nanoparticles. Hemoglobin level was not significantly
different between treatment and control (Anova; P> 0.01).
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the OFT method is done by inserting red blood cells in a
solution that is isotonic, hypertonic to hypotonic in
various concentrations. The usual concentration range
is 3-9%. If hemolysis occurs in a slightly hypotonic
solution, there is an increase in erythrocyte fragility
(decreased erythrocyte resistance), whereas if hemolysis
occurs in very hypotonic solutions it shows a decrease
in osmotic fragility (increased erythrocyte resistance).
The results of erythrocyte fragility testing at
Table 1, showed that the initial hemolysis of erythrocytes
in groups of rats given magnetic nanoparticle injection
and control after four weeks ranged in the range of 5-6%
NaCl concentration. The total hemolysis point of the
control group was in the range of 4% NaCl concentration,
while the value for treated rats was in the range of 4-5%
NaCl concentration. This result show that injection of
magnetic colloid did not give increasing pressure which
will cause any preliminary hemolysis of erythrocyte
membranes. Previous studies have reported that poly
ethylene glycol (PEG) nanoparticles are also not harmful
to the integrity of erythrocyte membranes [24]. Hou et
al. [25] also succeeded in synthesizing polyethersulfone
immobilized heparin nanoparticles (PES) and their use
only caused less than 5% of the lysis of erythrocytes in
the 9% NaCl concentration. Thus, these magnetic
nanoparticles prepare in this research have the potential
to be applied in the field of pharmacology.
Blood Chemistry
Blood chemistry was tested on liver and kidney
to identify effect of colloid injection to their function.
Generally, kidney conditions are evaluated by looking
at creatinine levels, Blood Ureum Nitrogen (BUN) and
total protein in the blood. Liver conditions were
evaluated from the conditions of albumin, globulin, total
bilirubin, Alanine Aminotransferase (ALT) and Alkaline
Phosphatase (ALP) in the blood. The kidneys will secrete
metabolic waste in the form of urea (from amino acid
metabolism), creatinine (from muscle keratin), uric acid
(from nucleic acid), the end product of hemoglobin
(bilirubin), hormone metabolites, and toxins (drugs and
pesticides) [26].
Creatinine and urea are indicators of renal
excretion function and increases when there is impaired
renal function [27]. The results of measurements in this
study at Table 2 showed that there were no significant
differences between treatment and control sample. The
absence of significant changes in the value of BUN,
creatinine and total protein is likely due to doses that
can still be tolerated by the body. Ali Ahmad et al. [28]
reported the use of Fe3O4 nanoparticles not coated with
chitosan at concentrations of 10-100 ppm / day did not
change BUN and creatinine levels in male Wistar rats,
whereas at higher concentrations (1000 ppm) it could
increase BUN and creatinine levels. This study proves
once again that the use of chitosan as a coating on Fe3O4
surface will lower the toxicity and give higher
concentrations of nanoparticles possibly used for in-
vivo application hence increasing the strength of
magnetic signal needed for drug delivery and MRI
contrast agent application.
More detailed results showed that magnetic
nanoparticles did not have a significant effect on liver
function seen from albumin, globulin, bilirubin, ALT and
ALP levels after four weeks of injection (Table 2). This
reinforces the notion that injection of magnetic
nanoparticles does not interfere with liver function which
is indicated by the absence of changes in blood
chemistry. Thus, these nanoparticles are not nephrotoxic.
Kumari et al. [29] investigated that the application of
Fe2O3 without coating on Wistar rats of females could
increase ASP, ALP, and lactate dehydrogenase in serum
and liver which indicated tissue necrosis in the liver due
to an adaptive mechanism caused by stress by
nanoparticles. This study proves that the use of magnetic
nanoparticles (Fe3O4) coated with chitosan does not
cause a response to such stress.
Blood Magnetism Analysis
The existence of magnetic particles can be
detected by analyzing its magnetic properties. Magnetic
properties of a material is formed from the arrangement /
regularity of the magnetic moments of the constituent
atoms in response to the signal of the external magnetic
field to the particle in a particular direction. A material is
said to have diamagnetic properties, if it gives a very
weak response and forms the arrangement of moments
in the opposite direction to the direction of the external
magnetic field. Paramagnetic properties possessed by
materials that provide a weak magnetic moment response
but are in line with the external magnetic field. Strong
Table 2. The blood chemistry of mice at 4 weeks after injection
of magnetic nanoparticles (Anova; P> 0.01).
Indicator Unit 
Control Treated 
level ± SD level ± SD 
BUN 
Creatinine 
Protein Total 
Albumin 
Globulin 
A/G Ratio 
Bilirubin Total 
ALT/SGPT* 
ALP** 
mg/dl 
mg/dl 
g/dl 
g/dl 
g/dl 
 
mg/dl 
U/I 
U/I 
19.48 ± 4.76 
0.80 ± 0.13 
5.13 ± 0.62 
2.68 ± 0.15 
2.45 ± 0.61 
1.13 ± 0.30 
0.21 ± 0.18 
60.23 ± 13.35 
391.50 ± 193.88 
24.50 ± 1.28 
0.77 ± 0.02 
5.17 ± 1.00 
2.70 ± 0.10 
2.47 ± 1.03 
1.20 ± 0.50 
0.06 ± 0.05 
68.43 ± 26.87 
427.90 ± 197.25 
 *ALT/SGPT: Alanine Aminotransferase/ Serum Glutamic Piruvic
Transaminase
**ALP:  Alkaline Phosphatase
Groups Initial Hemolysis 
(%) 
Total Hemolysis 
(%) 
Control 
Treated 
5-6 
5-6 
4 
4-5 
Table 1. Fragility of rat erythrocyte membranes at
4 weeks after injection of magnetic nanoparticles
(Anova; P> 0.01)
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Figure 5. Magnetic hysteresis curve of blood control
samples ((a), rats 7) and those injected with magnetic
nanoparticles ((b), rats 6) on day 8 after injection.
(a)
(b)
Figure 6. Maximum magnetic values of blood of control
rat (a) and magnetic nanoparticles (b) treated rat after 29
days of observation. Treated rats tend to have higher and
more stable magnetic values compared to lower and fluc-
tuating values of controls samples.
responses are given by ferromagnetic materials which
have high magnetic moments per atom and interact to
form a composition of moments in the direction of the
external magnetic field with certain regularities. This
material if it is very small to the nanoscale will decrease
its interaction so that it has a weaker response and forms
a paramagnetic response to a low magnetic field.
Magnetic interactions get stronger as the external
magnetic field increases and bring back the ferromagnetic
response which gives overall superparamagnetic
properties to magnetic nanoparticles.
The magnetism of this material can be analyzed
from its magnetic hysteresis curve which is measured
using magnetometer equipment. Magnetic nanoparticle
of Fe3O4,  especially in bulk particle size, has
ferromagnetic magnetic properties with saturated
magnetization values   reaching 92 emu / gram. In this
study, we used ~ 20 nm Fe3O4 particles coated with
chitosan, which has superparamagetic properties with
saturated magnetization, Ms = 74 emu / gram and 68 emu
/ gram for samples before and after chitosan coating
respectively [9]. Chitosan coated nanoparticles were
dispersed in water medium and formed stable magnetic
colloid with magnetic nanoparticle concentration of 5
mg/ml.
Magnetic interactions between nanoparticles in
the form of colloid will be weaker because they are
blocked by water around the nanoparticles so that the
magnetism decreases even though superparamagnetic
properties are still reflected. Upon injecting this colloid
into a blood vessel will cause further dilution by blood
fluids so that the magnetic nanoparticle concentration
decreases and the nanoparticles are more far apart from
each other. Magnetic interactions between particles are
increasingly blocked and reduce the strength of their
interactions. Figure 5 shows the hysteresis curve of the
blood sample for both the control (a), and those injected
with magnetic colloid (b) after 8th day of injection. The
hysteresis curve shows paramagnetic properties in both
samples, which magnetic values   (magnetic moments) is
higher for treated samples, showing the existence of
magnetic nanoparticles within the blood sample.
Paramagnetic properties in control samples can
be explained from Fe ions contained in blood. Injection
of magnetic nanoparticles, adds the amount of magnetic
moments in the blood, thereby increasing the total
moment value as indicated by the increase in the blood
paramagnetic curve. Figure 6 shows a graph of the
maximum magnetic value of blood in treated and control
rats after 29 days of treatment. The magnetic values in
injected rat blood increased until the 7th day and then
dropped. The decrease is probably caused by
nanoparticles that have been degraded by the body or
have been distributed to organs. On the other hand,
control rats tend to have lower maximum magnetism
values and fluctuate without a pattern. This graph has a
tendency similar to the pattern of changes in leukocytes
and hemoglobin shown in Figure 2 and Figure 4.
CONCLUSION
The injection of chitosan-coated magnetic
nanoparticles to a concentration value of 1 ml / Kg body
weight relatively did not give a significant change to the
blood profile of all baseline hematology parameter, i.e
the number of erythrocytes, the number of leukocytes,
the percentage of hematocrit, and hemoglobin levels.
The presence of magnetic nanoparticles in the blood
also tends to be stable which is indicated by the maximum
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magnetic value of the blood. In addition, magnetic
nanoparticles up to these doses did not affect the
condition of erythrocyte fragility and blood chemistry.
Based on these characters, magnetic nanoparticles have
no negative impact on blood profiles and have the
potential to be applied as drug carriers and MRI contrast
agents.
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